跳至主要内容
临床试验/NCT05221437
NCT05221437已完成不适用

Personalised Risk Assessment in Febrile Illness to Optimise Real-life Management Across the European Union (PERFORM)

Imperial College London0 个研究点目标入组 38,480 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
38,480
主要终点
Antibiotic prescription

研究概览

简要总结

This is an observational study assessing the management and outcome of children presenting to Emergency Departments (ED) with fever across Europe.

详细描述

This is an observational study assessing the management and outcome of children presenting to Emergency Departments (ED) with fever across Europe. This study will use large departmental datasets to collect information on at least 50,000 febrile episodes . This study will use large-scale, pseudo-anonymized departmental data, and will not involve consented patient recruitment; nor will it use patient samples. Data included in MOFICHE will be based on that collected as part of routine clinical care. Antibiotic prescription, hospitalisation and number/type of investigations, re-attendance at ED within 5 days of the first hospital presentation will be recorded.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • aged 0- 18 years visiting the emergency care.
  • fever measured at ED or history of (measured) fever less than 3 consecutive days prior to presentation at emergency department

排除标准

  • 未提供

结局指标

主要结局

Antibiotic prescription

时间窗: one year

number of antibiotic prescriptions

Number of investigations

时间窗: one year

number of investigations

Number of children re-attending within 5 days of the first hospital presentation.

时间窗: one year

Number of re-attendance

hospitalization

时间窗: one year

number of children requiring admission to hospital

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验